Latest news
-
A pulse check for health apps: when does software become a medical device?
- CAP News
- 08 October 2026
-
Bag a Bargain, Not a Breach: Black Friday and the CAP Code
- CAP News
- 08 October 2026
-
Handle with care: Advice on advertising to new and expectant parents
- CAP News
- 24 September 2026
-
No more grey areas: fair representations for every generation
- CAP News
- 24 September 2026
-
Quit non-compliance – filtered tips for stop-smoking ads
- CAP News
- 10 September 2026
-
Regulating the Illusion of Intelligence in Ads
- CAP News
- 27 August 2026
Latest rulings
-
Menwell Ltd t/a Do Health
- Upheld
- Social media (own site)
- 07 October 2026
Two ads for a health app incorporating a blood testing programme misleadingly implied that their blood tests could prevent and diagnose medical conditions or that their service could provide more tailored specific advice than pre-existing advice, without the evidence to support these claims.
-
BioIdentical Hormone Therapy Ltd t/a BioID Health
- Upheld
- Social media (paid ad)
- 26 August 2026
Two paid-for Facebook ads for a hormone health consultant made misleading claims that they could provide more effective tests and services for low testosterone than GPs and were irresponsible by implying that GPs were insufficiently thorough.
-
Fenix Biomed BV
- Upheld
- Website (own site)
- 19 August 2026
A website for a human tissue donation service misleadingly implied they were based in the UK.
-
HealthTracker Apps t/a Blood Pressure Monitor App
- Upheld
- App (paid ad)
- 17 June 2026
Two paid-for in-app ads for a health app made medical claims for a product that wasn’t registered as a medical device and misleadingly implied that their app could monitor blood pressure and heart rate.

